Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial

Metabolism: Clinical and Experimental

Volumn 56, Issue 12, 2007, Pages 1694-1698

  MacKenzie, Todd ^a   Comi, Richard ^a   Sluss, Patrick ^b   Keisari, Ronit ^a   Manwar, Simone ^a   Kim, Janice ^a   Larson, Robin ^a   Baron, John A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CAFFEINE; GLUCOSE; HYDROCORTISONE; INSULIN; MELATONIN; PLACEBO; PRASTERONE;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG METABOLISM; GLUCOSE ASSAY; GLUCOSE METABOLISM; HOMEOSTASIS; HORMONE METABOLISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN SENSITIVITY; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SALIVA ANALYSIS;

ADULT; ANDROSTENEDIONE; BLOOD GLUCOSE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DEHYDROEPIANDROSTERONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; INSULIN; MALE; MELATONIN; SALIVARY GLANDS;

EID: 35848957921     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.07.013     Document Type: Article

References (48)

1. Fredholm B.B., et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev (1999) 83-133
2. Greer F., et al. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes (2001) 2349-2354
3. Johnston K.L., Clifford M.N., and Morgan L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 78 (2003) 728-733
4. Thong F.S., et al. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 51 (2002) 583-590
5. Battram D.S., et al. The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J Nutr 136 (2006) 1276-1280
6. Lane J.D., et al. Caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 27 (2004) 2047-2048
7. Robinson L.E., et al. Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J Nutr 134 (2004) 2528-2533
8. van Dam R.M., Pasman W.J., and Verhoef P. Effects of coffee consumption on fasting blood glucose and insulin concentrations: randomized controlled trials in healthy volunteers. Diabetes Care (2004) 2990-2992
9. Lovallo W.R., et al. Stress-like adrenocorticotropin responses to caffeine in young healthy men. Pharmacol Biochem Behav 55 (1996) 365-369
10. al'Absi M., et al. Hypothalamic-pituitary-adrenocortical responses to psychological stress and caffeine in men at high and low risk for hypertension. Psychosom Med 60 (1998) 521-527
11. Nickell P.V., and Uhde T.W. Dose-response effects of intravenous caffeine in normal volunteers. Anxiety 1 (1994) 161-168
12. Charney D.S., Heninger G.R., and Jatlow P.I. Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 42 (1985) 233-243
13. Lovallo W.R., et al. Caffeine and behavioral stress effects on blood pressure in borderline hypertensive Caucasian men. Health Psychol 15 (1996) 11-17
14. Shepard J.D., et al. Additive pressor effects of caffeine and stress in male medical students at risk for hypertension. Am J Hypertens 13 5 Pt 1 (2000) 475-481
15. Lane J.D. Neuroendocrine responses to caffeine in the work environment. Psychosom Med 56 (1994) 267-270
16. Spindel E.R., et al. Neuroendocrine effects of caffeine in normal subjects. Clin Pharmacol Ther 36 (1984) 402-407
17. Gilbert D.G., et al. Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilance. Psychophysiology 37 (2000) 583-595
18. Wright Jr. K.P., et al. Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res 747 (1997) 78-84
19. Wright Jr. K.P., et al. Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives. Brain Res 873 (2000) 310-317
20. Shilo L., et al. The effects of coffee consumption on sleep and melatonin secretion. Sleep Med 3 (2002) 271-273
21. Ursing C., et al. Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450(CYP)1A2. J Endocrinol Invest 26 (2003) 403-406
22. Babkoff H., et al. Single-dose bright light and/or caffeine effect on nocturnal performance. Aviat Space Environ Med 73 (2002) 341-350
23. Lewy A.J., et al. Light suppresses melatonin secretion in humans. Science 210 (1980) 1267-1269
24. Matthews D.R., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
25. Wallace T.M., Levy J.C., and Matthews D.R. Use and abuse of HOMA modeling. Diabetes Care 27 (2004) 1487-1495
26. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab (2000) 4426-4433
27. Hills M., and Armitage P. The two-period cross-over clinical trial. Br J Clin Pharmacol 8 (1979) 7-20
28. Piantadosi S. Clinical trials: a methodologic perspective (1997), Wiley, New York xxi, 590
29. Team R.D.C. R: a language and environment for statistical computing (2005), R Foundation for Statistical Computing, Vienna, Austria
30. Graham T.E., et al. Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Can J Physiol Pharmacol (2001) 559-565
31. Johnston K.L., Clifford M.N., and Morgan L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr (2003) 728-733
32. Keijzers G.B., et al. Caffeine can decrease insulin sensitivity in humans. Diabetes Care (2002) 364-369
33. Pizziol A., et al. Effects of caffeine on glucose tolerance: a placebo-controlled study. Eur J Clin Nutr 52 (1998) 846-849
34. Cheraskin E., et al. Effect of caffeine versus placebo supplementation on blood-glucose concentration. Lancet (1967) 1299-1300
35. Poehlman E.T., et al. The effect of prior exercise and caffeine ingestion on metabolic rate and hormones in young adult males. Can J Physiol Pharmacol 67 (1989) 10-16
36. Brown C.R., and Benowitz N.L. Caffeine and cigarette smoking: behavioral, cardiovascular, and metabolic interactions. Pharmacol Biochem Behav 34 (1989) 565-570
37. van Dam R.M., Pasman W.J., and Verhoef P. Effects of coffee consumption on fasting blood glucose and insulin concentrations: randomized controlled trials in healthy volunteers. Diabetes Care 27 (2004) 2990-2992
38. Naismith D.J., et al. The effect, in volunteers, of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Nutr Metab 12 (1970) 144-151
39. Battram D.S., et al. The effect of caffeine on glucose kinetics in humans-influence of adrenaline. J Physiol 569 (2005) 347-355
40. Roden M., et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97 (1996) 2859-2865
41. Iso H., et al. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 144 (2006) 554-562
42. van Dam R.M., and Hu F.B. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294 (2005) 97-104
43. Greenberg J.A., Boozer C.N., and Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr 84 (2006) 682-693
44. Salazar-Martinez E., et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140 (2004) 1-8
45. Pereira M.A., Parker E.D., and Folsom A.R. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 166 (2006) 1311-1316
46. Lovallo W.R., et al. Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women. Pharmacol Biochem Behav 83 (2006) 441-447
47. Hartter S., et al. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. Br J Clin Pharmacol 56 (2003) 679-682
48. Juliano L.M., and Griffiths R.R. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 176 (2004) 1-29